All Studies

Antioxidant polysaccharide-enriched fractions obtained from olive leaves by ultrasound-assisted extraction with α-amylase inhibition, and antiproliferative activities.

Researchers extracted polysaccharide-rich materials from olive leaves, finding antioxidant, alpha-amylase inhibition, and antiproliferative activities. The extract showed potential for functional food development due to synergistic effects of its compounds.

Elayeb R et al (2024).
3 Biotech.
PubMed:
38425411

Baseline symptom severity and efficacy of Silexan in patients with anxiety disorders: A symptom-based, patient-level analysis of randomized, placebo-controlled trials.

Silexan, an essential oil, is effective in treating anxiety disorders, especially in early stages. Baseline severity influences treatment outcome, with more severe symptoms showing greater improvement. Helpful for mild to moderate cases.

Dold M et al (2024).
Eur Psychiatry.
PubMed:
38425206

Discovery of New Antimicrobial Metabolites in the Coculture of Medicinal Mushrooms.

Coculture extracts of SY630 with SY341 or SY1001 improved antifungal activity. New compounds discovered, some show comparable activity to fluconazole/nystatin. Isolated sphingolipids downregulate ergosterol biosynthesis, a promising mechanism against antibiotic-resistant fungi.

Ji L et al (2024).
J Agric Food Chem.
PubMed:
38425052

Antiproliferative and Antimigratory Activity of Poly-gallic Acid in Cancer Cell Lines.

Scientists modified molecules to create potential cancer treatment with low toxicity. Tested on liver, breast, and prostate cancer cells, showing promise for treatment with good cell compatibility.

Hernandez-Valencia CG et al (2024).
Anticancer Res.
PubMed:
38423672

Therapeutic potential of CB(1)R activation by Qingyangshen glycoside M1 for seizure relief.

Researchers investigated the potential anti-epileptic properties of glycosides from Qingyangshen (QYS), a traditional medicine. Understanding the mechanisms of action could lead to new treatments for neurological disorders.

Mu X et al (2024).
J Ethnopharmacol.
PubMed:
38423411

Morindone as a potential therapeutic compound targeting TP53 and KRAS mutations in colorectal cancer cells.

Morindone, a compound from Morinda citrifolia, shows promise as a potential anticancer agent for colorectal cancer with mutated TP53 and KRAS genes, exhibiting anti-proliferative and pro-apoptotic effects through multiple mechanisms.

Chee CW, Mohd Hashim N and Nor Rashid N (2024).
Chem Biol Interact.
PubMed:
38423379